EVOFEM BIOSCIENCES, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
EVOFEM BIOSCIENCES, INC. (EVFM) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $2.57 million as of 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2025-03-24
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $2.57M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $2.51M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $3.37M.
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $3.51M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits as first filed |
|---|---|---|
| 2024-12-31 | $2.57M 10-K · filed 2025-03-24 | |
| 2023-12-31 | $2.51M 10-K · filed 2025-03-24 | |
| 2022-12-31 | $3.37M 10-K · filed 2024-03-27 | |
| 2021-12-31 | $3.51M 10-K · filed 2023-04-27 | |
| 2020-12-31 | $3.84M 10-K · filed 2022-03-10 | |
| 2019-12-31 | $3.37M 10-K · filed 2021-03-04 | |
| 2018-12-31 | $3.90M 10-K · filed 2020-03-12 | |
| 2017-12-31 | $1.39M 10-K · filed 2019-03-01 | $51.00K 10-K · filed 2018-02-26 |
| 2016-12-31 | $2.29M 8-K/A · filed 2018-04-06 | $46.00K 10-K · filed 2017-03-23 |
| 2015-12-31 | $138.00K 10-K · filed 2017-03-23 | |
| 2014-12-31 | $286.00K 10-K · filed 2016-03-29 |